These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 17275264)

  • 41. Bovine dialyzable leukocyte extract modulates the nitric oxide and pro-inflammatory cytokine production in lipopolysaccharide-stimulated murine peritoneal macrophages in vitro.
    Franco-Molina MA; Mendoza-Gamboa E; Castillo-León L; Tamez-Guerra RS; Rodríguez-Padilla C
    J Med Food; 2005; 8(1):20-6. PubMed ID: 15857204
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protective role of angiopoietin-1 in endotoxic shock.
    Witzenbichler B; Westermann D; Knueppel S; Schultheiss HP; Tschope C
    Circulation; 2005 Jan; 111(1):97-105. PubMed ID: 15611372
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prostaglandin synthetase inhibitors in endotoxin or septic shock--a review.
    Fletcher JR
    Adv Shock Res; 1983; 10():9-14. PubMed ID: 6410700
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dimethyl cardamonin inhibits lipopolysaccharide-induced inflammatory factors through blocking NF-kappaB p65 activation.
    Kim YJ; Ko H; Park JS; Han IH; Amor EC; Lee JW; Yang HO
    Int Immunopharmacol; 2010 Sep; 10(9):1127-34. PubMed ID: 20609401
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TLR2 activation causes no morbidity or cardiovascular failure, despite excessive systemic nitric oxide production.
    Cauwels A; Vandendriessche B; Bultinck J; Descamps B; Rogge E; Van Nieuwenhuysen T; Sips M; Vanhove C; Brouckaert P
    Cardiovasc Res; 2013 Oct; 100(1):28-35. PubMed ID: 23787001
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A nitric oxide-releasing salbutamol elicits potent relaxant and anti-inflammatory activities.
    Lagente V; Naline E; Guenon I; Corbel M; Boichot E; Burgaud JL; Del Soldato P; Advenier C
    J Pharmacol Exp Ther; 2004 Jul; 310(1):367-75. PubMed ID: 15084649
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endotoxin as a therapeutic target in septic shock.
    Corriveau CC; Danner RL
    Infect Agents Dis; 1993 Feb; 2(1):35-43. PubMed ID: 8162352
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacodynamic profile of telithromycin against macrolide- and fluoroquinolone-resistant Streptococcus pneumoniae in a neutropenic mouse thigh model.
    Tessier PR; Mattoes HM; Dandekar PK; Nightingale CH; Nicolau DP
    Antimicrob Agents Chemother; 2005 Jan; 49(1):188-94. PubMed ID: 15616295
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Syneilesis palmata (Thunb.) Maxim. extract attenuates inflammatory responses via the regulation of TRIF-dependent signaling and inflammasome activation.
    Han JW; Shim DW; Shim EJ; Kim MK; Shin YK; Kwak SB; Koppula S; Kim TJ; Kang TB; Lee KH
    J Ethnopharmacol; 2015 May; 166():1-4. PubMed ID: 25747147
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nitric oxide and septic shock. From bench to bedside.
    Kuhl SJ; Rosen H
    West J Med; 1998 Mar; 168(3):176-81. PubMed ID: 9549416
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chemokines and liver inflammation: the battle between pro- and anti-inflammatory mediators.
    Jaeschke H
    Hepatology; 1997 Jan; 25(1):252-3. PubMed ID: 8985302
    [No Abstract]   [Full Text] [Related]  

  • 52. Mediators: nitric oxide and other toxic oxygen species.
    Evans TJ; Cohen J
    Curr Top Microbiol Immunol; 1996; 216():189-207. PubMed ID: 8791741
    [No Abstract]   [Full Text] [Related]  

  • 53. Effect of protein C and activated protein C on alveolar fibrin deposition and turnover in a piglet model of septic shock.
    Veldman A; Fischer D; Nold M; Schranz D; Bloch Münster AM
    J Thromb Haemost; 2006 Nov; 4(11):2488-90. PubMed ID: 16911639
    [No Abstract]   [Full Text] [Related]  

  • 54. Ketoconazole and nitric oxide.
    Bogle R; Vallance P
    Crit Care Med; 1995 Mar; 23(3):600. PubMed ID: 7874916
    [No Abstract]   [Full Text] [Related]  

  • 55. Septic shock: the cardiovascular abnormality and therapy.
    Natanson C; Hoffman WD; Parrillo JE
    J Cardiothorac Anesth; 1989 Apr; 3(2):215-27. PubMed ID: 2519950
    [No Abstract]   [Full Text] [Related]  

  • 56. The influence of antiglucocorticoids on stress and shock.
    Lázár G; Lázár G; Husztik E; Duda E; Agarwal MK
    Ann N Y Acad Sci; 1995 Jun; 761():276-95. PubMed ID: 7625726
    [No Abstract]   [Full Text] [Related]  

  • 57. Significance and pathogenesis of septic shock.
    Brandtzaeg P
    Curr Top Microbiol Immunol; 1996; 216():15-37. PubMed ID: 8791734
    [No Abstract]   [Full Text] [Related]  

  • 58. Molecules and mechanisms operating in septic shock: lessons from knockout mice.
    Gutierrez-Ramos JC; Bluethmann H
    Immunol Today; 1997 Jul; 18(7):329-34. PubMed ID: 9238836
    [No Abstract]   [Full Text] [Related]  

  • 59. Mechanisms of action and clinical application of macrolides as immunomodulatory medications.
    Kanoh S; Rubin BK
    Clin Microbiol Rev; 2010 Jul; 23(3):590-615. PubMed ID: 20610825
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The anti-inflammatory activity of telithromycin in a mouse model of septic shock.
    Leiva M; Ruiz-Bravo A; Moreno E; Jimenez-Valera M
    Int J Antimicrob Agents; 2007 Mar; 29(3):364-5. PubMed ID: 17275264
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.